These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14028528)

  • 1. [Treatment of shock, considered irreversible, with angiotensin and aldosterone].
    DOMINGUEZ JB; GOMEZ R; PRIETO ME
    Rev Med Chil; 1963 Jan; 91():9-14. PubMed ID: 14028528
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
    Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
    Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular synthesis of aldosterone: role in hypertension.
    Takeda Y
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):75-9. PubMed ID: 15134804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Emmett N; Socci RR; Eatman D; Fridie IL
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
    Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
    Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New strategy in the treatment of hypertension: inhibition of renin-angiotensin-aldosterone system with renin inhibitor].
    Pál L; Kalina A
    Orv Hetil; 2006 Apr; 147(17):785-9. PubMed ID: 16780186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A; Feely J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes.
    Karalliedde J; Viberti G
    J Hum Hypertens; 2006 Apr; 20(4):239-53. PubMed ID: 16452996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.
    Hannila-Handelberg T; Kontula K; Tikkanen I; Tikkanen T; Fyhrquist F; Helin K; Fodstad H; Piippo K; Miettinen HE; Virtamo J; Krusius T; Sarna S; Gautschi I; Schild L; Hiltunen TP
    BMC Med Genet; 2005 Jan; 6():4. PubMed ID: 15661075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of rennin-angiotensin-aldosterone system genes and NO synthase gene to the development of arterial hypertension].
    Savinetskaia GA; Golubeva AA; Pogoda TV; Generozov EV
    Klin Med (Mosk); 2008; 86(8):12-7. PubMed ID: 18819340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of aldosterone and angiotensin II in insulin resistance: an update.
    Lastra-Lastra G; Sowers JR; Restrepo-Erazo K; Manrique-Acevedo C; Lastra-González G
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):1-6. PubMed ID: 19138313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of aldosterone on the intradermal test with angiotensin].
    DE MARTINIS C; FONZO D
    Boll Soc Ital Biol Sper; 1963 Mar; 39():330-2. PubMed ID: 14025918
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of renin-angiotensin-aldosterone system gene polymorphisms on blood pressure response to antihypertensive treatment.
    Jiang X; Sheng HH; Lin G; Li J; Lu XZ; Cheng YL; Huang J; Xiao HS; Zhan YY
    Chin Med J (Engl); 2007 May; 120(9):782-6. PubMed ID: 17531119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.